Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 43 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
421 19.0 months Metastatic breast cancer 4 Biologic therapy
Chemotherapy
Kyoto University Japan 3/2012
Treatment Details: Patients: This phase 2 study involved 19 female metastatic breast cancer patients who had received prior anthracycline-based chemotherapy. The median patient age was 54 years. Treatment:
 
422 19.0 months Relapsed or refractory aggressive mantle cell lymphoma 4 Biologic therapy
Chemotherapy
The University of Texas M. D. Anderson Cancer Center United States 11/2008
Treatment Details: Patients: This phase 2 study involved 31 relapsed or refractory aggressive mantle cell lymphoma patients. The median patient age was 63 years and the male to female ratio was 5 to 1. Tre
 
423 19.0 months Recurrent epithelial ovarian cancer 5 Biologic therapy
Chemotherapy
St Joseph's Hospital United States 6/2014
Treatment Details: Patients: This phase 3 study involved recurrent epithelial ovarian cancer patients who were divided into two treatment groups. Group A had 458 patients with a median age of 59 years, while
 
424 19.0 months NHL 5 Immunotherapy
Seoul National University Korea 12/2011
Treatment Details: Patients: This study involved 38 non-Hodgkin lymphoma patients who had previously received chemotherapy and autologous stem cell transplant. The median patient age was 37 years and 68.4% w
 
425 18.9 months Metastatic colorectal carcinoma 5 Chemotherapy
Instituto do Câncer do Estado de São Paulo Brazil 10/2012
Treatment Details: Patients: This study involved previously untreated metastatic colorectal carcinoma patients who were divided into two separate treatment groups. Group A consisted of 502 patients with a me
 
426 18.9 months Recurrent Ovarian Cancer 5 Biologic therapy
Princess Margaret Cancer Centre Canada 7/2015
Treatment Details: Patients: This phase 2 study involved 74 recurrent ovarian, peritoneal, or fallopian tube cancer patients who had received prior platinum-based chemotherapy. The median patient age was 58
 
427 18.9 months GBM 4 Chemotherapy
Radiation
Seoul National University Hospital Korea 11/2010
Treatment Details: Patients: In this study, glioblastoma patients were separated into two different treatment groups. Group A consisted of 42 patients with a median age of 51.1 years, 35.7% of whom were male
 
428 18.9 months Metastatic colorectal cancer 5 Chemotherapy
Austin Health Australia 7/2010
Treatment Details: Patients: This study involved patients with metastatic colorectal cancer who were divided into 3 separate treatment groups. Group A consisted of 156 patients with a median age of 69 years
 
429 18.9 months Metastatic colorectal cancer 5 Biologic therapy
Chemotherapy
Austin Health Australia 7/2010
Treatment Details: Patients: This study involved patients with metastatic colorectal cancer who were divided into 3 separate treatment groups. Group A consisted of 156 patients with a median age of 69 years
 
430 18.8 months Advanced renal cell carcinoma 4 Biologic therapy
Chemotherapy
Memorial Sloan-Kettering Cancer Center United States 9/2007
Treatment Details: Patients: This phase I/II study involved seventy-one patients with stage IV renal cell carcinoma. Of these patients, 39 (55%) had prior therapy. The majority of patients (76%) were men,
 
Page 43 of 187  | Previous Page  | Next Page